Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT07107165
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoetic Stem Cell Transplant
  • Hematopoetic Stem Cell Transplantation
  • Stem Cell Transplant

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dyadic Problem Solving Training — BEHAVIORAL
    DPST consists of teaching the patient and family caregiver problem-solving skills that they can apply to help them manage the medical regimen after stem cell transplant.
  • Supportive Care — BEHAVIORAL
    Supportive Care consists of providing support to the patient and family caregiver as they manage the medical regimen after stem cell transplant

Study Details

Adherence to the medical regimen after stem cell transplant is challenging for both patients and their family caregivers. The investigators propose a randomized clinical trial testing two brief psychosocial interventions to determine if either improves patient and family caregiver psychosocial and health-related outcomes.

Key Dates

Start date
Jul 1, 2025
Status verified
Mar 2026
Primary completion
Jun 30, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
208 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Dyadic Problem Solving Training (DPST)
    DPST will teach problem solving skills to both the patient and family caregiver as they manage the medical regimen.
  • Active Comparator: Supportive Care
    Supportive Care will provide support to both the patient and family caregiver as they manage the medical regimen.

Primary Outcome Measure

Health Habits Assessment - modified for stem cell transplant [ Time Frame: 1-, 5-, 12- and 24-weeks post-intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Pittsburgh Medical Center Hillman Cancer CenterPittsburghPennsylvania15232
Donna Posluszny, PhD
[email protected]
412-623-5966
Donna Posluszny, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By research site
University of Pittsburgh Medical Center Hillman Cancer Center· Pittsburgh, PA

Related Studies